SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Another 10 U.S. tankers are headed to Israel's Ben Gurion as airport delays mount

OpenAI uncovers more rogue AI incidents as scrutiny of frontier models intensifies

Full list of Israeli startup M&As in 2026

Razer acquires StreamElements in rescue deal after months of uncertainty

Buzz

Most popular

Daily

Weekly

1

Israel searches for technology that could find soldiers and pilots who cannot call for help

2

Another 10 U.S. tankers are headed to Israel's Ben Gurion as airport delays mount

3

After IAI and Rafael, secretive missile engine maker Tomer moves toward an IPO

4

ServiceNow continues layoffs as it restructures around AI

5

Israel's Iron Dome and Arrow makers unlikely to reach the IPO market before 2027 as Tomer joins the queue

Entera Bio

3 stories about Entera Bio

נאסד"ק וול סטריט

Fourth Time’s the Charm for Entera Bio IPO

01.07.18|Dror Reich

The Israel-based oral drug developer listed on Nasdaq on Thursday, pricing 1.4 million units of one share and one warrant at $8 each

תרופות טבע גלולות תרופה

Entera Bio Files for Nasdaq IPO

12.11.17|Lilach Baumer

The clinical stage company develops treatments mostly for osteoporosis and bone disorders

IPO Hopeful Entera Bio Moves to Better Position

13.09.17|Dror Reich

Clinical-stage company Entera Bio develops pioneering technology for orphan disease hypoparathyroidism